Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01997840
Title ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Acetylon Pharmaceuticals Incorporated

multiple myeloma


Dexamethasone + Pomalidomide + Ricolinostat

Age Groups: adult
Covered Countries USA | ITA | CAN

No variant requirements are available.